Reuben holds 18 years of commercial biopharmaceutical industry experience.

Prior to co-founding Link Biologics, Reuben worked for Novo Nordisk in various leadership roles including Business Unit Head, Global Life Cycle Management Lead for a >$1bn product portfolio, and Global Product Director for multiple early-stage assets targeting billion-dollar markets.

Reuben holds an MSc in Drug Design from University College London (UCL).

Tony is a Professor of Biochemistry within the Manchester Cell-Matrix Centre (University of Manchester), where he is Lead for Translation.

Tony was elected to the Academy of Europe in 2012 and was formerly a member of the Council of the International Society for Matrix Biology (2016-2019) and President of the International Society for Hyaluronan Sciences (2021-2023).

Tony holds a DPhil in Biochemistry from the University of Oxford and has worked on TSG-6 for >30 years.

Caroline is a Senior Lecturer in Immune Response & Disease at the University of Manchester, where she is also the Lead for Postgraduate Research within the Division of Cell Matrix Biology and Regenerative Medicine.

Caroline holds a DPhil in Biochemistry from the University of Oxford and has expertise in protein expression, molecular and cellular biology, and in vivo models. She has worked on TSG-6 for >20 years, co-leading multiple basic research and translational programmes and securing significant funding.

Lorna holds over 20 years of biopharmaceutical R&D experience across academic and industry sectors.

Prior to joining Link Biologics, Lorna served as R&D Director at Cambrian Bio, Associate Director of Research at Oxstem, and Principal Scientist & Programme Manager at e-therapeutics, where she led multidisciplinary teams from early discovery through to clinical strategy.

Lorna holds a PhD in Cell Biology from Cardiff University.

Jasmin has 20 years of finance experience across biotech, SaaS, and multinational sectors.

Prior to joining Link Biologics, Jasmin held senior finance leadership roles at CBRE, Price f(x) AG, Community Brands and Summit Therapeutics INC, where she led strategic initiatives to turn around failing finance functions, oversaw statutory, compliance, audit and established best practices.

Jasmin is a Fellow Chartered Certified Accountant (FCCA) and holds a BA Honours in Business Economics from Kingston University.

Nikos is a biochemist with over 15 years of experience in protein engineering, inflammation, and translational biology research.

Prior to joining Link Biologics, Nikos held postdoctoral positions at the Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, and the Hellenic Pasteur Institute, where he led projects on therapeutic proteins for inflammatory diseases.

Nikos holds a PhD in Biochemistry from the University of Nottingham.